Back to Trades
ABERNETHY MATT
Chief Financial OfficerCIK 0001724097
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 2
- Active
- 2026
ABERNETHY MATT, Chief Financial Officer, accounts for 5 disclosed filings worth $7.8M, spread across 2 companies, active 2026. The record is heavily weighted toward selling, with $0 in purchases against $363.3K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Sep 15 | NBIX NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Sell | $363.3K |
| Jun 15 | FATE FATE THERAPEUTICS INC | ABERNETHY MATT | Insider | Award | $181.1K |
| Mar 5 | NBIX NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Gift | $0 |
| Feb 17 | NBIX NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Grant | $6.6M |
| Feb 3 | NBIX NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Exercise | $186.1K |
5 filings